{"entity":{"type":"insider","cik":"0001552047","url":"/insider/0001552047","json_url":"/insider/0001552047.json","name":"Horton Kenneth L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":5,"first":"2013-07-10","last":"2022-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Horton Kenneth L","source":"filing","n_filings":5,"first_seen":"2013-07-10","last_seen":"2022-02-14"}],"transactions":[{"id":6565314,"accession":"0001209191-22-009555","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-009555","line_url":"/filing/0001209191-22-009555#line-2","is_derivative":false,"issuer_cik":"0001552047","issuer_name":"Senseonics Holdings, Inc.","issuer_ticker":"SENS","issuer_name_source":null,"issuer_url":"/issuer/0001552047","owner_cik":"0001552047","owner_name":"Horton Kenneth L","owner_display_name":"Horton Kenneth L","owner_url":"/insider/0001552047","role":"Officer (GC & Corp. Development Advisor)","role_mark":"O","role_mark_label":"Officer (GC & Corp. Development Advisor)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"GC & Corp. Development Advisor","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143126.0,"shares_display":"143,126","price_per_share":2.46,"price_display":"2.46","price_state":"stated","total_value":352089.96,"total_display":"352,089.96","total_whole":"352,090","shares_owned_after":1217425.0,"shares_owned_after_display":"1,217,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":6708957,"accession":"0001209191-14-060597","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-060597","line_url":"/filing/0001209191-14-060597","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001552047","owner_name":"Horton Kenneth L","owner_display_name":"Horton Kenneth L","owner_url":"/insider/0001552047","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36000.0,"shares_display":"36,000","price_per_share":112.68556416666667,"price_display":"112.69","price_state":"stated","total_value":4056680.31,"total_display":"4,056,680.31","total_whole":"4,056,680","shares_owned_after":49464.0,"shares_owned_after_display":"49,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2014-10-01","scope":"insider","n_lines":4},{"id":6383793,"accession":"0001209191-14-046017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-046017","line_url":"/filing/0001209191-14-046017","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001552047","owner_name":"Horton Kenneth L","owner_display_name":"Horton Kenneth L","owner_url":"/insider/0001552047","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30134.0,"shares_display":"30,134","price_per_share":95.22082995951418,"price_display":"95.22","price_state":"stated","total_value":2869384.49,"total_display":"2,869,384.49","total_whole":"2,869,384","shares_owned_after":32463.0,"shares_owned_after_display":"32,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-01","filed_date":"2014-07-03","scope":"insider","n_lines":2},{"id":5339332,"accession":"0001209191-13-056696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-056696","line_url":"/filing/0001209191-13-056696#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001552047","owner_name":"Horton Kenneth L","owner_display_name":"Horton Kenneth L","owner_url":"/insider/0001552047","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4532.0,"shares_display":"4,532","price_per_share":65.46,"price_display":"65.46","price_state":"stated","total_value":296664.72,"total_display":"296,664.72","total_whole":"296,665","shares_owned_after":16624.0,"shares_owned_after_display":"16,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-12","filed_date":"2013-12-12","scope":"insider"},{"id":5430284,"accession":"0001209191-13-036101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-036101","line_url":"/filing/0001209191-13-036101","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001552047","owner_name":"Horton Kenneth L","owner_display_name":"Horton Kenneth L","owner_url":"/insider/0001552047","role":"Officer (EVP & Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813.0,"shares_display":"1,813","price_per_share":80.7184225041368,"price_display":"80.72","price_state":"stated","total_value":146342.5,"total_display":"146,342.50","total_whole":"146,343","shares_owned_after":20976.0,"shares_owned_after_display":"20,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-08","filed_date":"2013-07-10","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001616543","name":"Senseonics Holdings, Inc.","url":"/issuer/0001616543","role":"Officer (GC & Corp. Development Advisor)","n_filings":1,"first_seen":"2022-02-14","last_seen":"2022-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP & Chief Legal Officer)","n_filings":4,"first_seen":"2013-07-10","last_seen":"2014-10-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001552047","retrieved_at":"2026-08-25T01:59:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}